High Potency Active Pharmaceutical Ingredients Market to Record Rapid Revenue Growth from 2022 to 2025 |Research Informatic
Highly potent active pharmaceutical ingredients (HPAPIs) are pharmacologically active substances with biological activity at extremely low concentrations, such as a daily therapeutic dose of 10 mg or an occupational exposure limit (OEL) of 10 g/m3 over an eight-hour time-weighted average.
The Global High Potency Active Pharmaceutical Ingredients Market is expected to reach $21.41 billion by 2026, growing at a CAGR of 9.1 percent between 2022 and 2026.